Directive

Mythos has established small teams of investment analysts for the purpose of identifying compelling market opportunities and performing diligence on behalf of the fund. These teams have a focus on a particular disease area or technology type. The program runs as 4-6 month cycles and candidates must have (1) a serious commitment to learning about biotech investing and (2) have strong technical or domain-specific expertise.

Become an analyst

Do you have a strong interest in biotechnology? Do you want to gain experience in conducting diligence and work in an investment team? Apply and send a message to the management team!